โ† All deals

Tempus AI, Inc.

Public Equity (NASDAQ)B2BSaaSBiotechnology
๐Ÿ“ Chicago, IL, United Statesโ€ข Founded 2015โ€ข 3800 employees
StreetZero Signal 68
Be the first to signal interest

About Tempus AI, Inc.

Tempus AI, Inc. (legal name Tempus Labs, Inc.) is a biotechnology research company founded in 2015 and headquartered in Chicago, IL. It operates a B2B SaaS platform that uses AI to process and analyze medical data, helping doctors improve patient treatment through precision medicine and diagnostics. The company went public on Nasdaq under ticker TEM in June 2024 after raising $410.7 million in its IPO at $37 per share.

LATEST FUNDINGRule 144
$15.9M
Announced 2026-11-19
TOTAL RAISED$2.75B
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Tempus AI, Inc..

Free plan includes 3 full deal profiles every month.

EMPLOYEES3800
FOUNDED2015
HQChicago, IL, United States
Industry
Public Equity (NASDAQ)
Tags
B2BSaaSBiotechnologyAIHealthcare

Key highlights

  • Completed Nasdaq IPO in June 2024 raising $410.7M at $37 per share with a $6B+ valuation.
  • Uses AI for medical data analysis and diagnostics in precision medicine.
  • Backed by Google and major growth investors including NEA and T. Rowe Price.
  • Maintains strategic collaborations with AstraZeneca, GSK, Merck and others.
  • Public company with 3,800 employees and over 139k LinkedIn followers.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account